Santa Cruz Biotechnology now offers a broad range of NOS2 Inhibitors. Nitric oxide (NO) has a broad range of biological activities including cell signaling pathways in phylogenetically diverse species. Nitric oxide synthases (NOSs), the enzymes responsible for synthesis of NO, contain an N-terminal oxygenase domain and a C-terminal reductase domain. The inducible form of NOS, NOS2 (also designated iNOS), is Ca2+-independent and is expressed in a variety of cell types. NOS2 Inhibitors offered by Santa Cruz inhibit NOS2 and, in some cases, other cell signaling and nitric oxide synthase related proteins. View detailed NOS2 Inhibitor specifications, including NOS2 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 41 to 50 of 61 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-[(4S)-4-amino-5-[(2-aminoethyl)amino]pentyl]-N′-nitroguanidine tris(trifluoroacetate) salt | 357965-99-2 | sc-215427 sc-215427A | 5 mg 25 mg | $151.00 $733.00 | 3 | |
N-[(4S)-4-amino-5-[(2-aminoethyl)amino]pentyl]-N'-nitroguanidine tris(trifluoroacetate) salt exhibits a unique mechanism of action with NOS2, characterized by its nitroguanidine moiety that facilitates hydrogen bonding with key amino acid residues. This interaction stabilizes the enzyme's conformation, potentially enhancing its catalytic activity. The trifluoroacetate component contributes to solubility and ionic interactions, influencing the compound's reactivity and overall dynamics within the enzymatic pathway. | ||||||
BYK 191023 dihydrochloride | 608880-48-4 | sc-361131 sc-361131A | 10 mg 50 mg | $161.00 $686.00 | 3 | |
BYK 191023 dihydrochloride is characterized by its ability to modulate NOS2 activity through specific electrostatic interactions. The dihydrochloride form enhances solubility, promoting effective diffusion in biological systems. Its unique structural features allow for selective binding to the enzyme's active site, influencing reaction kinetics and substrate affinity. This compound's distinct behavior as an acid halide facilitates the formation of transient intermediates, impacting downstream signaling pathways. | ||||||
1,3-PBITU, Dihydrobromide | sc-3568 | 10 mg | $20.00 | 1 | ||
1,3-PBITU, Dihydrobromide exhibits a remarkable capacity to influence NOS2 through its unique molecular architecture, which fosters specific hydrogen bonding interactions. The dihydrobromide variant enhances its reactivity, allowing for rapid formation of reactive intermediates. This compound's distinctive electronic properties facilitate selective interactions with NOS2, altering enzymatic activity and modulating downstream effects in cellular signaling networks. Its behavior as an acid halide contributes to its dynamic reactivity profile. | ||||||
L-thiocitrulline, Dihydrochloride | 212051-53-1 | sc-3572 sc-3572A | 10 mg 50 mg | $62.00 $245.00 | ||
L-thiocitrulline, Dihydrochloride showcases intriguing interactions with NOS2, primarily through its thiol group, which can form covalent bonds with key residues in the enzyme. This compound's unique stereochemistry influences its binding affinity, promoting specific conformational changes in NOS2. Additionally, its dihydrochloride form enhances solubility, facilitating rapid diffusion and interaction kinetics, ultimately impacting nitric oxide production and related signaling pathways. | ||||||
MEG sodium succinate | 1190-74-5 (non-salt) | sc-221879 | 10 mg | $200.00 | ||
MEG sodium succinate exhibits notable interactions with NOS2, characterized by its ability to modulate enzyme activity through competitive inhibition. The compound's unique structure allows for effective binding to the active site, influencing the enzyme's conformational dynamics. Its ionic nature enhances solubility in aqueous environments, promoting efficient molecular interactions. Furthermore, the presence of the succinate moiety facilitates specific electrostatic interactions, optimizing reaction kinetics and influencing downstream signaling pathways. | ||||||
S-(3-Aminopropyl)-ITU dihydrobromide | 7072-40-4 | sc-205971 sc-205971A | 10 mg 50 mg | $30.00 $62.00 | ||
S-(3-Aminopropyl)-ITU dihydrobromide demonstrates intriguing interactions with NOS2, primarily through allosteric modulation rather than direct competition. Its unique amine functional group enables specific hydrogen bonding, altering the enzyme's structural conformation and enhancing substrate affinity. The dihydrobromide form increases solubility, facilitating rapid diffusion and interaction in biological systems. Additionally, its distinct electronic properties may influence redox states, impacting enzymatic activity and regulatory mechanisms. | ||||||
S-Isopropylisothiourea hydrobromide | 57200-31-4 | sc-204252 sc-204252A | 10 mg 50 mg | $85.00 $359.00 | ||
S-Isopropylisothiourea hydrobromide exhibits a unique mechanism of action with NOS2, characterized by its ability to form stable complexes that influence enzyme kinetics. The isopropyl group enhances hydrophobic interactions, promoting a favorable binding environment. This compound's thiourea moiety can engage in specific electrostatic interactions, modulating the enzyme's active site dynamics. Its hydrobromide salt form improves solubility, allowing for efficient cellular uptake and interaction with nitric oxide synthase pathways. | ||||||
Propenyl-L-NIO (hydrochloride) | sc-222191 sc-222191A | 5 mg 10 mg | $67.00 $127.00 | |||
Propenyl-L-NIO (hydrochloride) is distinguished by its selective inhibition of NOS2, facilitated by its unique propenyl group that enhances steric hindrance, thereby altering enzyme conformation. The hydrochloride form increases solubility, promoting effective interaction with the enzyme. Its molecular structure allows for specific hydrogen bonding and hydrophobic interactions, which fine-tune the binding affinity and modulate the catalytic activity of nitric oxide synthase, influencing downstream signaling pathways. | ||||||
Xanthomegnin | 1685-91-2 | sc-364147 sc-364147A | 500 µg 1 mg | $203.00 $344.00 | ||
Xanthomegnin exhibits a distinctive mechanism of action as a NOS2 inhibitor, characterized by its ability to form stable complexes with the enzyme through specific electrostatic interactions. Its unique structural features promote conformational changes in NOS2, enhancing selectivity. The compound's reactivity as an acid halide facilitates nucleophilic attack, leading to rapid modifications of target residues, which can significantly impact enzyme kinetics and regulatory pathways in cellular signaling. | ||||||
MEG, Hydrochloride | 19767-44-3 | sc-364694 | 10 mg | $225.00 | ||
MEG, Hydrochloride acts as a potent NOS2 inhibitor, distinguished by its capacity to engage in hydrogen bonding and hydrophobic interactions with the enzyme's active site. This compound's unique electronic properties allow for enhanced binding affinity, promoting allosteric modulation of NOS2 activity. Its behavior as an acid halide enables efficient acylation of nucleophilic sites, influencing reaction rates and altering downstream signaling cascades within cellular environments. | ||||||